Company Profile

TheraTech Inc (AKA: Watson Laboratories Inc)
Profile last edited on: 8/5/2024      CAGE: -----      UEI: ----------

Business Identifier: Drug-delivery company that develops, manufactures and markets innovative products based on its patented and proprietary technologies and systems
Year Founded
1985
First Award
1985
Latest Award
1998
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

417 Wakara Way
Salt Lake City, UT 84108
   (801) 588-6200
   N/A
   N/A
Location: Single
Congr. District: 02
County: Salt Lake

Public Profile

TheraTech is now a subsidiary of the publicly traded company Watson Pharmaceuticals also based in Salt Lake City UT. The firm now is focused to develops controlled-release and other drug delivery products for conditions ranging from angina to anxiety. Its products are administered through the skin, orally, and by inhalation. Products include a testosterone transdermal system for men (Androderm) and a transdermal osteoporosis product for women (Alora). The company's consumer products subsidiary, Natrapac, offers antiwrinkle patch Face Lift through a licensing agreement. In addition to its FDA-approved products, TheraTech has 20 other drug-delivery products in the pipeline. TheraTech has alliances with such companies as SmithKline Beecham, Eli Lilly, Pfizer, and Procter & Gamble

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
150-249
Revenue Range
15M-20M
VC funded?
No
Public/Private
Publicly Traded
Stock Info
NASDAQ : TTI
IP Holdings
25-49

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1998 1 NIH $100,000
Project Title: Peptide Based Therapy for Rheumatoid Arthritis
1986 1 NIH $50,000
Project Title: Long acting polymer/fouride mouthrinse
1985 1 NIH $45,850
Project Title: Cancer Chemotherapy Is Widely Used and New and More Potent Antineoplastic Drugs Are Being Continually Developed

Key People / Management

  Ramesh K Prakash

Company News

There are no news available.